Clinical trials: Intra-abdominal Infection
Peritoneal Contamination After Ileocolonic Anastomosis, Wound Infection
Microbiological Spectrum of the Intraperitoneal Surface After Elective Right-sided Colon Cancer
Despite performing colonic surgery with strict asepsia measures, minimizing the contact of the colon lumen with the peritoneum, some contamination is nearly impossible to avoid.
- Conditions
- Peritoneal Contamination After Ileocolonic Anastomosis, Wound Infection, Intra-abdominal Abscess
- Trial name
- NCT01458353
- Testing
- Stapled anastomosis, Handsewn anastomosis
- Where
- Spain
- Volunteers
- 80 people
- Sponsor
- Hospital General Universitario Elche
Intra-Abdominal Infection
T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam
The aim of the study was to compare the activity (efficacy and safety) of Ertapenem administered according to a short treatment for three days versus a short treatment for three days with AS in patients with an community acquired…
- Trial name
- TEA (NCT00630513)
- Testing
- Ertapenem, Ampicillin-Sulbactam
- Where
- Italy
- Volunteers
- 142 people
- Sponsor
- University of Bologna
Intra-abdominal Infection
A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
On the basis of monotherapy for intra-abdominal infection, the investigators are conducting this study to identify the difference of drug efficacy between ampicillin/sulbactam and moxifloxacin.
- Trial name
- NCT00952796
- Testing
- moxifloxacin, ampicillin/sulbactam
- Where
- Taiwan
- Volunteers
- 100 people
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Complicated Skin and Skin Structure Infections, Complicated Intra-abdominal Infections
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.
- Trial name
- NCT00683332
- Testing
- Tigecycline (Tygacil)
- Where
- Philippines
- Volunteers
- 621 people
- Sponsor
- Pfizer
Abscess, Intra-Abdominal, Cholecystitis
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
The primary objective is to collect data on treatment outcomes (clinical and microbiological cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with serious intra-abdominal and hepatobiliary…
- Conditions
- Abscess, Intra-Abdominal, Cholecystitis, Wound Infections, Peritonitis
- Trial name
- NCT00463762
- Testing
- CP-75385-02 Cefoperazone/sulbactam
- Sponsor
- Pfizer
Intra-abdominal Infection
Study Evaluating the Etiology of Intra-Abdominal Infections
The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific enterococcal antimicrobial…
- Trial name
- NCT00244088
- Volunteers
- 340 people
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
Complicated Intra-Abdominal Infections
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
The objectives of the study were: 1. To study risk factors for colonization and infection with antibiotic resistant bacteria among patients with severe IAI before and after antibiotic treatment and surgical intervention. 2.
- Trial name
- Bakki (NCT00860587)
- Volunteers
- 200 people
- Sponsor
- University Hospital, Linkoeping